# Source: Pentax C2 CryoBalloon Acquisition Announcement

**Type:** source
**Status:** Useful
**Confidence:** Medium
**Source Type:** Press Release
**URL:** https://www.utahbusiness.com/press-releases/2025/10/22/merit-medical-signs-asset-purchase-pentax-medical-acquire-c2-cryoballoon-technology/
**Publisher:** Utah Business (republished press release)
**Accessed:** 2026-05-09
**Updated:** 2026-05-09

## Summary

October 2025 press-release coverage announcing Merit Medical Systems' asset purchase of the C2 CryoBalloon gastrointestinal cryotherapy product line from Pentax Medical, with manufacturing transferring to South Jordan, Utah.

## Useful Claims

- Merit Medical (NASDAQ: MMSI) acquired Pentax Medical's C2 CryoBalloon technology in October 2025.
- Manufacturing of the C2 CryoBalloon line is being transferred into Merit's South Jordan facility.
- The transaction is consistent with Merit's broader pattern of acquiring adjacent interventional technologies and integrating them into its Utah footprint.

## Reliability Notes

Press releases are leads, not neutral evidence. Reliable for what each party publicly committed to; not reliable for forward-looking financial or clinical claims. The Utah Business republication is a content-syndication channel rather than independent reporting.

## Related Pages

- [Merit Medical Systems](merit-medical.md)